去中心化科学引发研究革命：VitaDAO 引领潮流

VitaDAO 是去中心化科学 (DeSci) 创新者，率先开展早期长寿研究，以提高预期寿命。利用 Molecule 的 IP-NFT 和 IPT 平台，它资助和开发现实世界中的科学举措。 IP-NFT 将区块链上的知识产权代币化，而 IPT（知识产权代币）代表科学知识产权的所有权，为社区赋能。 VitaDAO 的首次 IPT 公开发售 VITA-FAST 针对正在进行的自噬研究。

Decentralized Science: Revolutionizing Funding and Collaboration in Scientific Research

去中心化科学：彻底改变科学研究的资助和合作

In the realm of scientific research, the path from groundbreaking discoveries to life-changing innovations is often fraught with obstacles. The "valley of death" looms large, threatening to stifle promising research projects due to a lack of funding and operational challenges. Moreover, even when products reach the market, they are often subject to significant markups.

在科学研究领域，从突破性发现到改变生活的创新的道路常常充满障碍。由于缺乏资金和运营挑战，“死亡之谷”赫然出现，有可能扼杀有前途的研究项目。此外，即使产品进入市场，它们也往往会大幅加价。

Decentralized Science (DeSci) emerges as a paradigm shift, leveraging blockchain technology to establish permissionless and community-controlled platforms for scientific research advancement and management. DeSci empowers researchers to secure funding, document their work, and share access to intellectual property, breaking free from the constraints of traditional grant funding and centralized control.

去中心化科学（DeSci）作为一种范式转变而出现，利用区块链技术建立无需许可和社区控制的平台，以促进科学研究的进步和管理。 DeSci 使研究人员能够获得资金、记录他们的工作并共享知识产权，从而摆脱传统资助和集中控制的限制。

VitaDAO: Spearheading the DeSci Movement

VitaDAO：引领 DeSci 运动

VitaDAO stands as a prominent player in the DeSci landscape, dedicated to funding early-stage longevity research projects. Its community encompasses hundreds of academic scientists, longevity researchers, pharmaceutical giants like Pfizer, and crypto industry heavyweights. Through collaborative voting, members shape VitaDAO's research funding decisions, fostering project incubation and commercialization.

VitaDAO 是 DeSci 领域的重要参与者，致力于资助早期长寿研究项目。其社区包括数百名学术科学家、长寿研究人员、辉瑞等制药巨头以及加密行业重量级人物。通过协作投票，成员制定 VitaDAO 的研究资助决策，促进项目孵化和商业化。

Powered by Molecule, a decentralized biotech protocol, VitaDAO has developed a pioneering platform that empowers researchers with flexible funding options. Molecule facilitates the creation of IP-NFTs, non-fungible tokens that embody full legal intellectual property (IP) rights and data control. Researchers can market these IP-NFTs to DAOs and their communities, generating funding and establishing a decentralized IP governance.

在去中心化生物技术协议 Molecule 的支持下，VitaDAO 开发了一个开创性的平台，为研究人员提供灵活的资助选择。 Molecule 促进 IP-NFT 的创建，这是体现完全合法知识产权 (IP) 和数据控制的不可替代代币。研究人员可以向 DAO 及其社区推销这些 IP-NFT，从而筹集资金并建立去中心化的 IP 治理。

IP-NFTs: A Novel Avenue for Research Funding

IP-NFT：研究资助的新途径

IP-NFTs are transformative instruments that enable researchers to access funding by selling their potential future IP to investors eager to acquire IP rights stemming from the research project. Access to research data is restricted to NFT owners, ensuring secure data access.

IP-NFT 是一种变革性工具，使研究人员能够通过将其潜在的未来知识产权出售给渴望获得研究项目知识产权的投资者来获得资金。研究数据的访问仅限于 NFT 所有者，确保数据访问的安全。

Moreover, IP-NFTs can be further tokenized into fungible tokens known as IP tokens (IPTs). These fungible tokens enable researchers to raise funds for their projects while granting governance rights to holders, effectively mimicking the mechanisms of initial coin offerings (ICOs) and initial decentralized offerings (IDOs).

此外，IP-NFT 可以进一步代币化为可替代代币，称为 IP 代币（IPT）。这些可替代代币使研究人员能够为其项目筹集资金，同时授予持有者治理权，有效模仿初始代币发行（ICO）和初始去中心化发行（IDO）的机制。

IPTs: Funding and Governance Empowerment

IPT：资金和治理赋权

Molecule's technology allows IP-NFT owners to transform their IP-NFTs into IP tokens, creating decentralized IP governance for each research project. The IP DAO, composed of IPT holders, assumes control over the project's IP licensing, financial rights, and management. This governance framework ensures that the public retains control over the drugs and products they ultimately use.

Molecule 的技术允许 IP-NFT 所有者将其 IP-NFT 转换为 IP 代币，为每个研究项目创建去中心化的 IP 治理。 IP DAO 由 IPT 持有者组成，负责项目的 IP 许可、财务权利和管理。这一治理框架确保公众保留对其最终使用的药品和产品的控制权。

VITA-FAST IPT: A Case Study in Crowdfunding

VITA-FAST IPT：众筹案例研究

VitaDAO's initial IPT launch, VITA-FAST, exemplifies the potential of IPTs. This token enables holders to directly support the work of Newcastle University's Korolchuk Lab, which aims to identify compounds that stimulate autophagy and rejuvenate aging cells.

VitaDAO 最初推出的 IPT VITA-FAST 体现了 IPT 的潜力。该代币使持有者能够直接支持纽卡斯尔大学 Korolchuk 实验室的工作，该实验室旨在识别刺激自噬和恢复衰老细胞活力的化合物。

The VITA-FAST fundraising campaign proved remarkably successful, exceeding its target by a factor of 1700%. This success underscores the feasibility of VitaDAO's technology and the power of improved liquidity to drive funding for specific projects within the VitaDAO ecosystem.

VITA-FAST 筹款活动非常成功，超出目标 1700%。这一成功凸显了 VitaDAO 技术的可行性以及提高流动性以推动 VitaDAO 生态系统内特定项目融资的力量。

VitaDAO's Impact on BioPharma

VitaDAO 对生物制药的影响

Since its inception, VitaDAO has forged partnerships with leading drug-related research projects. It has reportedly raised over $10 million for human-related research and allocated over $4 million to longevity research. VitaDAO's global reach welcomes participation from individuals worldwide, contributing to its impact on BioPharma.

自成立以来，VitaDAO 已与领先的药物相关研究项目建立了合作伙伴关系。据报道，该公司已筹集了超过 1000 万美元用于人类相关研究，并拨款超过 400 万美元用于长寿研究。 VitaDAO 的全球影响力欢迎世界各地的个人参与，为其对生物制药的影响做出贡献。

Enhancing Collaboration and Liquidity

加强协作和流动性

VitaDAO empowers researchers to document their projects on an immutable blockchain layer through NFTs, providing verifiable proof of ownership. This flexibility fosters collaborations, as researchers can create bounties to incentivize other laboratories to contribute data in exchange for a share of the collectively developed IP.

VitaDAO 使研究人员能够通过 NFT 在不可变的区块链层上记录他们的项目，从而提供可验证的所有权证明。这种灵活性促进了合作，因为研究人员可以设立赏金来激励其他实验室贡献数据，以换取共同开发的知识产权的份额。

Through its partnership with bio.xyz, an accelerator and meta-governance platform, VitaDAO enables BioDAOs to fund, govern, and develop tokenized IP from universities, companies, and researchers globally. This collaboration catalyzes a surge of community-led translational science, leveraging shared resources, mentorship, and a suite of legal and smart contracts.

通过与加速器和元治理平台 bio.xyz 的合作，VitaDAO 使 BioDAO 能够资助、管理和开发来自全球大学、公司和研究人员的代币化知识产权。这种合作利用共享资源、指导以及一套法律和智能合约，促进了社区主导的转化科学的蓬勃发展。

Improving Drug Development Quality and Cost-Effectiveness

提高药物开发质量和成本效益

VitaDAO believes that granting patients and researchers governance over medicines will enhance drug development quality and cost-effectiveness. IPTs facilitate collaboration without sacrificing the commercial incentives that drive progress in traditional entities. By empowering patients and researchers, who are directly invested in effective cures, VitaDAO aims to foster higher quality research at lower costs.

VitaDAO 认为，赋予患者和研究人员对药物的治理权将提高药物开发质量和成本效益。 IPT 促进协作，同时又不牺牲推动传统实体进步的商业激励措施。通过为直接投资于有效治疗的患者和研究人员提供支持，VitaDAO 旨在以更低的成本促进更高质量的研究。

Discoverability of Projects: Bridging the Gap

项目的可发现性：弥合差距

Academic research often faces discoverability challenges, making it difficult for investors to identify promising projects. VitaDAO bridges this gap through its partnership with Molecule, a biopharma IP marketplace. Researchers and biotech companies can showcase their projects and discoveries on Molecule, expanding their reach to a wider network of investors, including VitaDAO. This enhanced discoverability empowers patients and biotech companies to support research projects aligned with their interests.

学术研究经常面临可发现性的挑战，使得投资者很难识别有前途的项目。 VitaDAO 通过与生物制药 IP 市场 Molecule 的合作弥补了这一差距。研究人员和生物技术公司可以在 Molecule 上展示他们的项目和发现，从而将他们的影响力扩大到更广泛的投资者网络，包括 VitaDAO。这种增强的可发现性使患者和生物技术公司能够支持符合他们兴趣的研究项目。

Conclusion: A Shift in Paradigm

结论：范式的转变

VitaDAO and DeSci herald a groundbreaking shift in scientific research. By embracing decentralization, blockchain technology empowers individuals to reclaim control over research funding, data, and intellectual property. Through IP-NFTs and IPTs, researchers can secure funding and establish community-driven governance for their projects, aligning incentives and fostering collaboration.

VitaDAO 和 DeSci 预示着科学研究的突破性转变。通过拥抱去中心化，区块链技术使个人能够重新控制研究经费、数据和知识产权。通过 IP-NFT 和 IPT，研究人员可以获得资金并为其项目建立社区驱动的治理，调整激励措施并促进合作。

As the DeSci narrative continues to evolve, it presents exciting possibilities for the future of scientific research. However, it is crucial to exercise due diligence before investing in any project, understanding the mechanisms and associated risks. This article serves as a comprehensive guide to the DeSci movement and VitaDAO's pivotal role, but it is not intended as financial or investment advice.

随着 DeSci 叙述的不断发展，它为科学研究的未来提供了令人兴奋的可能性。然而，在投资任何项目之前进行尽职调查、了解其机制和相关风险至关重要。本文作为 DeSci 运动和 VitaDAO 关键作用的综合指南，但无意作为财务或投资建议。